The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29

JD Young, SYM Yao, JM Baldwin, CE Cass… - Molecular aspects of …, 2013 - Elsevier
Nucleoside transport in humans is mediated by members of two unrelated protein families,
the SLC28 family of cation-linked concentrative nucleoside transporters (CNTs) and the …

Molecular biology of nucleoside transporters and their distributions and functions in the brain

F E. Parkinson, V L. Damaraju, K Graham… - Current topics in …, 2011 - benthamdirect.com
Pyrimidine and purine nucleosides and their derivatives have critical functions and
pharmacological applications in the brain. Nucleosides and nucleobases are precursors of …

The benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease

L Chouchana, C Narjoz, P Beaune… - Alimentary …, 2012 - Wiley Online Library
Aliment Pharmacol Ther 2012; 35: 15–36 Summary Background Thiopurines represent an
effective and widely prescribed therapy in inflammatory bowel disease (IBD). Concerns …

ABC transporters and their role in nucleoside and nucleotide drug resistance

Y Fukuda, JD Schuetz - Biochemical pharmacology, 2012 - Elsevier
ATP-binding cassette (ABC) transporters confer drug resistance against a wide range of
chemotherapeutic agents, including nucleoside and nucleotide based drugs. While …

Transporter-mediated protection against thiopurine-induced hematopoietic toxicity

P Krishnamurthy, M Schwab, K Takenaka, D Nachagari… - Cancer research, 2008 - AACR
Thiopurines are effective immunosuppressants and anticancer agents, but intracellular
accumulation of their active metabolites (6-thioguanine nucleotides, 6-TGN) causes dose …

Revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring

SZ Lim, EW Chua - Frontiers in pharmacology, 2018 - frontiersin.org
Azathioprine and 6-mercaptopurine, often referred to as thiopurine compounds, are
commonly used in the management of inflammatory bowel disease. However, patients …

ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer

X Zhao, Y Guo, W Yue, L Zhang, M Gu… - OncoTargets and …, 2014 - Taylor & Francis
Background Multidrug resistance protein 4 (MRP4), also known as ATP-cassette binding
protein 4 (ABCC4), is a member of the MRP/ABCC subfamily of ATP-binding cassette …

The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease

H Ban, A Andoh, H Imaeda, A Kobori, S Bamba… - Journal of …, 2010 - Springer
Background Multidrug resistance protein 4 (MRP4) functions as an efflux pump of
nucleoside monophosphate analogs, such as 6-mercaptopurine (6-MP) and 6-thioguanine …

Multiple forms of DNA damage caused by UVA photoactivation of DNA 6‐thioguanine

R Brem, P Karran - Photochemistry and photobiology, 2012 - Wiley Online Library
Thiopurines are prescribed frequently as medication for cancer and for inflammatory
disorders. One of them, azathioprine, has been the immunosuppressant of choice for organ …

[HTML][HTML] Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells

XX Peng, AK Tiwari, HC Wu, ZS Chen - Chinese journal of cancer, 2012 - ncbi.nlm.nih.gov
Imatinib, a breakpoint cluster region (BCR)-Abelson murine leukemia (ABL) tyrosine kinase
inhibitor (TKI), has revolutionized the treatment of chronic myelogenous leukemia (CML) …